Kepos Capital’s SAB Biotherapeutics SABS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-62,500	Closed	-$6.3M	–	668
2021 Q3	$6.3M	Buy	62,500 +9,677	+18%	+$975K	0.42%	40
2021 Q2	$5.26M	Buy	+52,823	New	+$5.26M	0.39%	92